• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number EVX35-08-040-080
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 08/22/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
An everflex entrust was used for treatment for a lesion in the patient¿ superficial femoral artery (sfa).This stent was to be implanted following recanalization for the previously closed pelvic flow path using a 5.5fr sheath from left to right in the external iliac.Previous everflex entrust was implanted in the iliac artery, and plan was to place this everflex entrust just reaching above the bifurcation (2 mm).Ifu was followed and the device was prepped without issues.It is reported on the way to the lesion resistance was experienced but physician was able to continue advancing the device.This led to the stent self-deploying in the aortic bifurcation.This was prior to releasing the red lock-pin.The stent was unfolded in the external iliac artery under fluoroscopy.The lock-pin remained in place and was pushed back a bit resulting in jutting from left to right in the external iliac.Through use of mechanical aids, the stent was stretched into the distal aorta where it is protruding 18-19 mm but the pelvic flow path is not affected.Patient will undergo stent explanation.Procedure date to be confirmed.
 
Manufacturer Narrative
Product analysis: the everflex entrust stent delivery system, (sds), was received for evaluation.No ancillary devices from the procedure were received for evaluation.The entrust sds was received with a kink near its distal end.The kink most likely happened post procedure given how the device was packaged for return.Backlighting of the distal end of the sds outer sheath revealed that the stent was not within the sds.Backlighting also revealed the location of the distal end of the inner guidewire lumen/pusher.The distal end of the inner guidewire lumen/pusher was marked on the exterior of the outer sheath.The distal end of the inner guidewire lumen/pusher is approximately 40mm proximal of the distal end of the outer sheath.The distal end of the inner guidewire lumen/pusher is at its position when it was released from manufacturing.The entire length of the sds catheter was examined.A second kink was noted approximately 77.3cm from the distal tip of the outer sheath at the distal tip of blue isolation sheath/strain relief.The kink most likely happened post-procedure given how the device was packaged for return.The entrust sds was received with the red safety tab still engaged with deployment handle.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9070038
MDR Text Key161776782
Report Number2183870-2019-00452
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P110023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/16/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/07/2022
Device Catalogue NumberEVX35-08-040-080
Device Lot NumberA780261
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/09/2019
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/15/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/08/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-